Literature DB >> 15168144

Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis.

Günşah Sahin1, Mukadder Calikoğlu, Cengiz Ozge, Nurgul Incel, Ali Biçer, Bahar Ulşubaş, Hayal Güler.   

Abstract

Pulmonary function is altered in ankylosing spondylitis (AS) owing mainly to the restriction of chest wall involvement (limited chest expansion). The objective of this study was to investigate the relationship between chest expansion, respiratory muscle strength (MIP, MEP) maximum voluntary ventilation (MVV), and BASFI score in patients with AS. Twenty-three male patients with definite AS and 21 age-matched healthy male controls were recruited for the study. Patients with AS were assessed for functional status by BASFI. Measurement of chest expansion and lumbar spinal flexion (modified Schober) method was performed in all subjects. Pulmonary function tests were performed by spirometry. Respiratory muscle strength was evaluated by a mouth-pressure meter (MPM). Body mass index (kg/m(2)) was recorded in all individuals. Chest expansion and modified Schober measurement were significantly lower in AS patients (p<0.05). Pulmonary function tests revealed restrictive lung disease. The mean BASFI score suggested good functional capacity in the AS group. The respiratory muscle strength and MVV were also lower in AS (p<0.05). The chest expansion was correlated with MIP and MEP values (r=0.491; p=0.02, r=0.436; p=0.05). Chest expansion was also correlated negatively with disease duration (r=-0.502; p=0.03). In addition, there was no correlation between chest expansion and BASFI score (r=-0.076; p=0.773). This study demonstrates that functional status (BASFI) is not influenced by the limitation of chest wall movement. It may be as a result of the maintenance of moderate physical activity during active life in patients with AS.

Entities:  

Mesh:

Year:  2004        PMID: 15168144     DOI: 10.1007/s10067-003-0850-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  Measurement of lung volumes.

Authors:  A L Ries
Journal:  Clin Chest Med       Date:  1989-06       Impact factor: 2.878

Review 2.  Spirometry and flow-volume curves.

Authors:  R M Gardner; R O Crapo; S B Nelson
Journal:  Clin Chest Med       Date:  1989-06       Impact factor: 2.878

3.  Shoulder muscle strength, endurance and electromyographic fatigue in ankylosing spondylitis.

Authors:  M Hagberg; I M Hagner; A Bjelle
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

4.  Inspiratory muscle fatigue as a factor limiting exercise.

Authors:  A Grassino; D Gross; P T Macklem; C Roussos; G Zagelbaum
Journal:  Bull Eur Physiopathol Respir       Date:  1979 Jan-Feb

5.  Maximal respiratory pressures: normal values and relationship to age and sex.

Authors:  L F Black; R E Hyatt
Journal:  Am Rev Respir Dis       Date:  1969-05

6.  An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis.

Authors:  R Carter; P Riantawan; S W Banham; R D Sturrock
Journal:  Respir Med       Date:  1999-10       Impact factor: 3.415

7.  Exercise performance of subjects with ankylosing spondylitis and limited chest expansion.

Authors:  C G Elliott; T R Hill; T E Adams; R O Crapo; R M Nietrzeba; R M Gardner
Journal:  Bull Eur Physiopathol Respir       Date:  1985 Jul-Aug

8.  Assessing inspiratory muscle strength in patients with neurologic and neuromuscular diseases : comparative evaluation of two noninvasive techniques.

Authors:  I Iandelli; M Gorini; G Misuri; F Gigliotti; E Rosi; R Duranti; G Scano
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Effect of reduced body weight on muscle aerobic capacity in patients with COPD.

Authors:  P Palange; S Forte; P Onorati; V Paravati; F Manfredi; P Serra; S Carlone
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

View more
  4 in total

1.  The efficiency of inspiratory muscle training in patients with ankylosing spondylitis.

Authors:  Bilge Basakci Calik; Elif Gur Kabul; Harun Taskın; Orcin Telli Atalay; Ummuhan Bas Aslan; Murat Tascı; Fahrettin Bıcakcı; Ali Ihsan Yıldız
Journal:  Rheumatol Int       Date:  2018-06-25       Impact factor: 2.631

2.  Pulmonary function in ankylosing spondylitis: association with clinical variables.

Authors:  A J L Brambila-Tapia; A D Rocha-Muñoz; L Gonzalez-Lopez; M Vázquez-Del-Mercado; M Salazar-Páramo; I P Dávalos-Rodríguez; L De la Cerda-Trujillo; M L Diaz-Toscano; P Hernandez-Cuervo; V Diaz-Rizo; D Sanchez-Mosco; J C Vazquez-Jimenez; E G Cardona-Muñoz; J I Gamez-Nava
Journal:  Rheumatol Int       Date:  2013-03-30       Impact factor: 2.631

3.  Effects of Pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a randomized controlled trial.

Authors:  Mihaela Oana Roşu; Ionuţ Ţopa; Rodica Chirieac; Codrina Ancuta
Journal:  Rheumatol Int       Date:  2013-09-26       Impact factor: 2.631

4.  Treatment of ankylosing spondylitis with biologics and targeted physical therapy: positive effect on chest pain, diminished chest mobility, and respiratory function.

Authors:  Z Gyurcsik; N Bodnár; Z Szekanecz; S Szántó
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.